ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -5.1% | 313,300 | +9.2% | 0.00% | – |
| Q2 2023 | $99 | -50.5% | 287,000 | +12.5% | 0.00% | – |
| Q1 2023 | $200 | -17.4% | 255,100 | +5.5% | 0.00% | – |
| Q4 2022 | $242 | -100.0% | 241,800 | -75.3% | 0.00% | -100.0% |
| Q3 2022 | $874,000 | +22.2% | 979,800 | +52.2% | 0.00% | 0.0% |
| Q2 2022 | $715,000 | -5.4% | 643,734 | +18.4% | 0.00% | 0.0% |
| Q1 2022 | $756,000 | -11.6% | 543,800 | +44.4% | 0.00% | 0.0% |
| Q4 2021 | $855,000 | +43.7% | 376,532 | +163.7% | 0.00% | 0.0% |
| Q3 2021 | $595,000 | +139.9% | 142,805 | +173.6% | 0.00% | – |
| Q2 2021 | $248,000 | -48.7% | 52,200 | -47.0% | 0.00% | -100.0% |
| Q4 2020 | $483,000 | +92.4% | 98,569 | -33.3% | 0.00% | – |
| Q3 2020 | $251,000 | +30.1% | 147,683 | +117.0% | 0.00% | – |
| Q2 2020 | $193,000 | +141.2% | 68,048 | +149.1% | 0.00% | – |
| Q1 2020 | $80,000 | -3.6% | 27,317 | +30.2% | 0.00% | – |
| Q4 2019 | $83,000 | – | 20,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 494,042 | $148,212 | 0.28% |
| Quantum Private Wealth, LLC | 459,187 | $137,757 | 0.07% |
| Pasadena Private Wealth, LLC | 278,750 | $83,625 | 0.02% |
| Beta Wealth Group, Inc. | 32,000 | $9,600 | 0.01% |
| BRIGHTON JONES LLC | 338,491 | $101,548 | 0.01% |
| Balboa Wealth Partners | 47,500 | $14,250 | 0.01% |
| Waypoint Capital Advisors, LLC | 26,271 | $7,882 | 0.00% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $16,243 | 0.00% |
| Aureus Asset Management, LLC | 30,211 | $9,063 | 0.00% |
| AXXCESS WEALTH MANAGEMENT, LLC | 70,363 | $21,109 | 0.00% |